These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 7562470

  • 1. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
    Cockcroft JR, Chowienczyk PJ, Brett SE, Chen CP, Dupont AG, Van Nueten L, Wooding SJ, Ritter JM.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1067-71. PubMed ID: 7562470
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
    van Lieburg AF, Knoers NV, Monnens LA, Smits P.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1695-700. PubMed ID: 8903635
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B, Erfanian M, Laurent K, Trochu JN, Gauthier C.
    J Am Coll Cardiol; 2009 Apr 28; 53(17):1532-8. PubMed ID: 19389564
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide mediated venodilator effects of nebivolol.
    Bowman AJ, Chen CP, Ford GA.
    Br J Clin Pharmacol; 1994 Sep 28; 38(3):199-204. PubMed ID: 7826820
    [Abstract] [Full Text] [Related]

  • 8. Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
    Prisant LM.
    J Clin Pharmacol; 2008 Feb 28; 48(2):225-39. PubMed ID: 18083889
    [Abstract] [Full Text] [Related]

  • 9. No-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by beta-adrenoceptors or by 5 HT1A-receptors.
    Chlopicki S, Kozlovski VI, Gryglewski RJ.
    J Physiol Pharmacol; 2002 Dec 28; 53(4 Pt 1):615-24. PubMed ID: 12512696
    [Abstract] [Full Text] [Related]

  • 10. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.
    Dawes M, Brett SE, Chowienczyk PJ, Mant TG, Ritter JM.
    Br J Clin Pharmacol; 1999 Sep 28; 48(3):460-3. PubMed ID: 10510163
    [Abstract] [Full Text] [Related]

  • 11. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
    Calver A, Collier J, Moncada S, Vallance P.
    J Hypertens; 1992 Sep 28; 10(9):1025-31. PubMed ID: 1328361
    [Abstract] [Full Text] [Related]

  • 12. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
    Gupta S, Wright HM.
    Cardiovasc Ther; 2008 Sep 28; 26(3):189-202. PubMed ID: 18786089
    [Abstract] [Full Text] [Related]

  • 13. Exploring vascular benefits of endothelium-derived nitric oxide.
    Cockcroft JR.
    Am J Hypertens; 2005 Dec 28; 18(12 Pt 2):177S-183S. PubMed ID: 16373196
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
    Campillo B, Chabrier PE, Pelle G, Sediame S, Atlan G, Fouet P, Adnot S.
    Hepatology; 1995 Nov 28; 22(5):1423-9. PubMed ID: 7590658
    [Abstract] [Full Text] [Related]

  • 15. Effects of nebivolol on human platelet aggregation.
    Falciani M, Rinaldi B, D'Agostino B, Mazzeo F, Rossi S, Nobili B, Rossi F, Filippelli A.
    J Cardiovasc Pharmacol; 2001 Dec 28; 38(6):922-9. PubMed ID: 11707696
    [Abstract] [Full Text] [Related]

  • 16. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
    Sacco G, Evangelista S, Criscuoli M, Goso C, Bigioni M, Binaschi M, Manzini S, Maggi CA.
    Eur J Pharmacol; 2005 Mar 28; 511(2-3):167-74. PubMed ID: 15792785
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.